Latest filing published 12 Apr 2016 for Spyre Therapeutics, Inc..
Insider track record
No signal scores available.
David George Lowe: trading record in brief
David George Lowe has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Oruka Therapeutics, Inc. and Spyre Therapeutics, Inc. Over a trading history stretching from 1 June 2009 to 12 April 2016, the count stands at 11 filings.
On the market, this insider has only sold: 9 sales, €1.2M in total.
Most recently, on 12 April 2016, the filings show a transaction in Spyre Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David George Lowe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,658 shares0Common StockSEC:0001140361-16-060929:0
- 25,000 shares@ US$4.19Common StockSEC:0001104659-09-044340:0
- 102,000 shares@ US$4.44Common StockSEC:0001104659-09-044340:1
- 78,800 shares@ US$3.94Common StockSEC:0001104659-09-044340:2
- 40,700 shares@ US$3.84Common StockSEC:0001123292-09-000619:0
- 3,800 shares@ US$3.94Common StockSEC:0001123292-09-000619:1
- 6,100 shares@ US$3.90Common StockSEC:0001123292-09-000619:2
- 342,375 shares0Common StockSEC:0001123292-09-000565:0
8 of 8 declarations
